These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33065857)

  • 1. Illustrated overview of vital cycle of Hepatitis C virus.
    Poulot A; Penin F
    Virologie (Montrouge); 2016 Feb; 20(1):E1-E31. PubMed ID: 33065857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Overview on duck virus hepatitis A].
    Ren L; Li J; Bi Y; Chen C; Zhang D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2012 Jul; 28(7):789-99. PubMed ID: 23167191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overview of hepatitis C virus from its discovery to now].
    Inoue K; Yoshiba M
    Rinsho Byori; 2001 Aug; 49(8):733-40. PubMed ID: 11573279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.
    Magri A; Barbaglia MN; Foglia CZ; Boccato E; Burlone ME; Cole S; Giarda P; Grossini E; Patel AH; Minisini R; Pirisi M
    Liver Int; 2017 May; 37(5):669-677. PubMed ID: 27885811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of infectious hepatitis C virus particles.
    Bartenschlager R; Penin F; Lohmann V; André P
    Trends Microbiol; 2011 Feb; 19(2):95-103. PubMed ID: 21146993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virology and cell biology of the hepatitis C virus life cycle: an update.
    Dubuisson J; Cosset FL
    J Hepatol; 2014 Nov; 61(1 Suppl):S3-S13. PubMed ID: 25443344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies.
    Puchades Renau L; Berenguer M
    Hemodial Int; 2018 Apr; 22 Suppl 1():S8-S21. PubMed ID: 29694724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.
    Zignego AL; Ferri C; Pileri SA; Caini P; Bianchi FB;
    Dig Liver Dis; 2007 Jan; 39(1):2-17. PubMed ID: 16884964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the research on non-A, non-B hepatitis: hepatitis C virus. Multicenter anti-HCV studies].
    Pár A
    Orv Hetil; 1990 Oct; 131(42):2295-8. PubMed ID: 2172888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis C virus RNA in liver tissue: an overview.
    Negro F
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):205-10. PubMed ID: 9675661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of efficacious pangenotypic hepatitis C virus therapies.
    Ashraf MU; Iman K; Khalid MF; Salman HM; Shafi T; Rafi M; Javaid N; Hussain R; Ahmad F; Shahzad-Ul-Hussan S; Mirza S; Shafiq M; Afzal S; Hamera S; Anwar S; Qazi R; Idrees M; Qureshi SA; Chaudhary SU
    Med Res Rev; 2019 May; 39(3):1091-1136. PubMed ID: 30506705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of new therapies].
    Ongaro M; Spahr L; Giostra E; Negro F
    Rev Med Suisse; 2020 Sep; 16(704):1538-1543. PubMed ID: 32880108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation.
    Honda M; Shimazaki T; Kaneko S
    Gastroenterology; 2005 Feb; 128(2):449-62. PubMed ID: 15685555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis of reactivation of hepatitis B and hepatitis C virus infection in immunosuppressive therapy].
    Risum M; Barfod TS
    Ugeskr Laeger; 2019 Feb; 181(6):. PubMed ID: 30729919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
    Qureshi SA
    Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hepatitis agents: the significance of clinical and experimental studies. An overview.
    Krawczynski K
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S193-4. PubMed ID: 9407338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis alphabet--hepatitis A-G and TTV.
    Müller C
    Wien Klin Wochenschr; 1999 Jun; 111(12):461-8. PubMed ID: 10420504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus: standard-of-care treatment.
    Pawlotsky JM
    Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.